Organic is generally a better way to for your health and also for your testosterone levels. It’s not because of anything special they put in the food or anything like that, it is because of what doesn’t go into the plants, things like pesticides and herbicides. Little do most people know that pesticides and herbicides are also contributors to lower testosterone. Studies have shown that the pesticide Chlorpyrifos has a negative effect on testosterone and this study showed that Chlorpyrifos has been found in more than 90% of Americans. Other pesticides such as Vinclozolin , Atrazine , and PCBs , have been linked to lower testosterone levels as well.
AndroGel (testosterone) for Hypogonadism, Male: "I am 33 was tested and had low t my results were 39 which is extremely low. I started on androgel two pumps made me very aggressive and I would snap and get angry so I went to 1 pump in the morning my sex drive went through the roof :) . After 6 wks I was tested the results were 432 that was exciting I also gained 15pounds I use to weigh 140 now I'm staying between 150-156 I am stronger more energy can think better but I do have my days that suck it's all part of the test now not everyone is going to have results like mine so keep trying to find what it is that works also if your eating poorly that maybe the reason also try to eat healthy and workout"
Testosterone, like many anabolic steroids, was classified as a controlled substance in 1991. Testosterone is administered parenterally in normal and delayed-release (depot) forms. In September 1995, the FDA approved testosterone transdermal patches (Androderm), and many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA-approved in July 2003; Striant is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation of testosterone (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA refused approval for Intrinsa in 2004 stating that more data regarding safety, especially in relation to cardiovascular and breast health, were required.